Next-generation biobanking and cell culture technology for pathophysiologically relevant in vitro tumor models Dr. Hella Bolck, senior research fellow in the Department of Pathology and Molecular Pathology at the University Hospital Zurich. Unraveling the causes and consequences of tumor cell heterogeneity is a main research goal for Dr. Hella […]
Editorial Article: 3D patient-derived cell models reflect tumor heterogeneity of clear cell renal cell carcinoma
